Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
Forrat R, Dayan GH, DiazGranados CA, Bonaparte M, Laot T, Capeding MR, Sanchez L, Coronel DL, Reynales H, Chansinghakul D, Hadinegoro SRS, Perroud AP, Frago C, Zambrano B, Machabert T, Wu Y, Luedtke A, Price B, Vigne C, Haney O, Savarino SJ, Bouckenooghe A, Noriega F. Forrat R, et al. Among authors: diazgranados ca. Clin Infect Dis. 2021 Sep 15;73(6):1003-1012. doi: 10.1093/cid/ciab288. Clin Infect Dis. 2021. PMID: 33822015 Free PMC article. Clinical Trial.
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial.
Rerks-Ngarm S, Pitisuttithum P, Excler JL, Nitayaphan S, Kaewkungwal J, Premsri N, Kunasol P, Karasavvas N, Schuetz A, Ngauy V, Sinangil F, Dawson P, deCamp AC, Phogat S, Garunathan S, Tartaglia J, DiazGranados C, Ratto-Kim S, Pegu P, Eller M, Karnasuta C, Montefiori DC, Sawant S, Vandergrift N, Wills S, Tomaras GD, Robb ML, Michael NL, Kim JH, Vasan S, O'Connell RJ; RV305 Study Team. Rerks-Ngarm S, et al. J Infect Dis. 2017 Apr 15;215(8):1255-1263. doi: 10.1093/infdis/jix099. J Infect Dis. 2017. PMID: 28329190 Free PMC article. Clinical Trial.
Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus.
Nascimento EJM, George JK, Velasco M, Bonaparte MI, Zheng L, DiazGranados CA, Marques ETA, Huleatt JW. Nascimento EJM, et al. Among authors: diazgranados ca. J Virol Methods. 2018 Jul;257:48-57. doi: 10.1016/j.jviromet.2018.03.007. Epub 2018 Mar 19. J Virol Methods. 2018. PMID: 29567514 Free article.
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, Savarino S, Zambrano B, Moureau A, Khromava A, Moodie Z, Westling T, Mascareñas C, Frago C, Cortés M, Chansinghakul D, Noriega F, Bouckenooghe A, Chen J, Ng SP, Gilbert PB, Gurunathan S, DiazGranados CA. Sridhar S, et al. Among authors: diazgranados ca. N Engl J Med. 2018 Jul 26;379(4):327-340. doi: 10.1056/NEJMoa1800820. Epub 2018 Jun 13. N Engl J Med. 2018. PMID: 29897841 Free article.
Evaluation of dengue serological tests available in Puerto Rico for identification of prior dengue infection for prevaccination screening.
Bonaparte M, Huleatt J, Hodge S, Zheng L, Lustig Y, DiazGranados CA, Ataman-Önal Y, Savarino S. Bonaparte M, et al. Among authors: diazgranados ca. Diagn Microbiol Infect Dis. 2020 Mar;96(3):114918. doi: 10.1016/j.diagmicrobio.2019.114918. Epub 2019 Oct 24. Diagn Microbiol Infect Dis. 2020. PMID: 31839333 Free article.
Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus.
Dayan GH, Langevin E, Gilbert PB, Wu Y, Moodie Z, Forrat R, Price B, Frago C, Bouckenooghe A, Cortes M, Noriega F, DiazGranados CA. Dayan GH, et al. Among authors: diazgranados ca. Vaccine. 2020 Apr 23;38(19):3531-3536. doi: 10.1016/j.vaccine.2020.03.029. Epub 2020 Mar 20. Vaccine. 2020. PMID: 32204943 Free article.
70 results